Le Lézard
Classified in: Health
Subject: RCL

Food Recall Warning (Allergen) - The Chocolate Lab brand Chocolate Coffee Beans recalled due to undeclared milk


OTTAWA, ON, Dec. 24, 2022 /CNW/ - Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/chocolate-lab-brand-chocolate-coffee-beans-recalled-due-undeclared-milk

Summary
Affected products

Brand                 

Product

Size

UPC                       

Codes

The Chocolate
Lab

Chocolate
Coffee Beans    

100 g    

7 03355 52587 6

23 MR 22    

Issue

The affected product is being recalled from the marketplace because it may contain milk which is not declared on the label.

The recalled product has been sold in Alberta and Ontario and online.

What you should do

Learn more:

Background

This recall was triggered by Canadian Food Inspection Agency test results.

There have been no reported reactions associated with the consumption of this product.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 16:42
Accelerate Diagnostics, Inc. today announced financial preliminary results for the first quarter ended March 31, 2024. "During the...

at 16:40
Johnson & Johnson will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer Taubert, Executive Vice President, Worldwide Chairman,...

at 16:37
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that it has set a record date of May 17, 2024 (the "Record Date") for the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary, Inhibrx...

at 16:35
DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today provided a business update and financial results for the quarter ended March...

at 16:35
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced new data from a study further confirming the performance of its DecisionDx-UM test as a robust independent predictor of...

at 16:30
Catalent, Inc. ("Catalent"), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for the third quarter of fiscal 2024, which ended March 31, 2024. "I am pleased to report...



News published on and distributed by: